Topic Archive

#Injective

4 Stories Found

Coins•Oct 16, 2026

Altcoins Outpace Bitcoin as Celestia Jumps 16% While Warsh Stays Silent on Interest-Rate Plans

Key Highlights Bitcoin traded steadily around $82,100 after rebounding from an intraday low of $81,600, holding securely above Thursday’s brief sub-$80,000 dip. Altcoins led broader market gains, lifting the CoinMarketCap Altcoin Season Index from 50 to 60, led by double-digit surges in Celestia alongside strong performances from Injective and LayerZero. Crypto derivatives liquidations dropped to ...

5 min readRead

Coins•Oct 5, 2026

Altcoin Eyes ETF Approval as Founder Sets Target Date Ahead of SEC Decision

Key Highlights: The United States cryptocurrency exchange-traded fund (ETF) market is expanding beyond Bitcoin and Ethereum to encompass a growing list of altcoins. Following regulatory filings and market interest surrounding major assets such as XRP, attention has shifted toward additional altcoin investment products. Injective (INJ) has emerged as the latest digital asset entering discussions for ...

3 min readRead

Coins•Sep 25, 2026

Canary Capital Amends Staked Injective ETF Filing with SEC, Sparking INJ Price Rally Speculation

Key Highlights Canary Capital has amended its S-1 filing with the SEC for a staked Injective (INJ) exchange-traded fund, signaling progress toward a regulated crypto investment product. The updated prospectus details structural changes designed to offer investors direct exposure to the Injective token and its native staking yield within a regulated framework. INJ token price ...

4 min readRead

Coins•Sep 8, 2026

Polkadot Leads Rotation Into Older Layer-1s as Rate-Hike Odds Widen

Pre-2018 Layer-1 Tokens Lead Tuesday Crypto Rally as Bitcoin, Ether Decline A cohort of layer-1 tokens launched before 2018 outperformed Tuesday while bitcoin and ether finished lower, and traders increased bets on a Federal Reserve rate hike next week. Only Polkadot among the group had a specific catalyst: holders are voting on a proposal to ...

11 min readRead